Id |
Subject |
Object |
Predicate |
Lexical cue |
T50 |
10-18 |
JJ |
denotes |
clinical |
T51 |
19-25 |
NNS |
denotes |
trials |
T52 |
26-31 |
VBP |
denotes |
exist |
T53 |
32-34 |
IN |
denotes |
on |
T54 |
35-38 |
DT |
denotes |
the |
T55 |
39-42 |
NN |
denotes |
use |
T56 |
43-45 |
IN |
denotes |
of |
T57 |
46-61 |
NNS |
denotes |
corticosteroids |
T58 |
62-65 |
IN |
denotes |
for |
T59 |
66-74 |
NN |
denotes |
COVID-19 |
T60 |
76-77 |
LS |
denotes |
• |
T61 |
79-82 |
NN |
denotes |
IL6 |
T62 |
83-93 |
VBZ |
denotes |
correlates |
T63 |
94-98 |
IN |
denotes |
with |
T64 |
99-107 |
NN |
denotes |
severity |
T65 |
107-108 |
-COMMA- |
denotes |
, |
T66 |
109-120 |
NN |
denotes |
criticality |
T67 |
120-121 |
-COMMA- |
denotes |
, |
T68 |
122-127 |
JJ |
denotes |
viral |
T69 |
128-132 |
NN |
denotes |
load |
T70 |
132-133 |
-COMMA- |
denotes |
, |
T71 |
134-137 |
CC |
denotes |
and |
T72 |
138-147 |
NN |
denotes |
prognosis |
T73 |
148-150 |
IN |
denotes |
of |
T74 |
151-159 |
NN |
denotes |
COVID-19 |
T75 |
161-162 |
IN |
denotes |
• |
T76 |
164-175 |
NNP |
denotes |
Tocilizumab |
T77 |
175-176 |
-COMMA- |
denotes |
, |
T78 |
177-179 |
DT |
denotes |
an |
T79 |
180-188 |
NN |
denotes |
anti-IL6 |
T80 |
188-189 |
-COMMA- |
denotes |
, |
T81 |
190-193 |
MD |
denotes |
can |
T82 |
194-200 |
VB |
denotes |
confer |
T83 |
201-208 |
NN |
denotes |
benefit |
T84 |
209-211 |
IN |
denotes |
in |
T85 |
212-220 |
NNS |
denotes |
patients |
T86 |
221-225 |
IN |
denotes |
with |
T87 |
226-234 |
NN |
denotes |
COVID-19 |
T88 |
235-238 |
CC |
denotes |
and |
T89 |
239-243 |
JJ |
denotes |
high |
T90 |
244-247 |
NN |
denotes |
IL6 |
T91 |
250-258 |
NN |
denotes |
Abstract |
T92 |
259-262 |
DT |
denotes |
The |
T93 |
263-268 |
JJ |
denotes |
novel |
T94 |
269-280 |
NN |
denotes |
coronavirus |
T95 |
280-281 |
-COMMA- |
denotes |
, |
T96 |
282-291 |
NN |
denotes |
SARS-CoV2 |
T97 |
291-292 |
-COMMA- |
denotes |
, |
T98 |
293-296 |
MD |
denotes |
can |
T99 |
297-302 |
VB |
denotes |
cause |
T100 |
303-304 |
DT |
denotes |
a |
T101 |
305-316 |
RB |
denotes |
potentially |
T102 |
317-322 |
JJ |
denotes |
fatal |
T103 |
323-330 |
NN |
denotes |
disease |
T104 |
330-331 |
-COMMA- |
denotes |
, |
T105 |
332-340 |
NN |
denotes |
COVID-19 |
T106 |
340-341 |
-COMMA- |
denotes |
, |
T107 |
342-344 |
IN |
denotes |
in |
T108 |
345-351 |
NNS |
denotes |
humans |
T109 |
353-357 |
RB |
denotes |
Here |
T110 |
357-358 |
-COMMA- |
denotes |
, |
T111 |
359-361 |
PRP |
denotes |
we |
T112 |
362-366 |
MD |
denotes |
will |
T113 |
367-374 |
VB |
denotes |
provide |
T114 |
375-377 |
DT |
denotes |
an |
R100 |
T99 |
T107 |
arg1Of |
cause,in |
R101 |
T108 |
T107 |
arg2Of |
humans,in |
R102 |
T113 |
T109 |
arg1Of |
provide,Here |
R103 |
T113 |
T110 |
arg1Of |
provide,"," |
R104 |
T111 |
T112 |
arg1Of |
we,will |
R105 |
T113 |
T112 |
arg2Of |
provide,will |
R106 |
T111 |
T113 |
arg1Of |
we,provide |
R46 |
T51 |
T50 |
arg1Of |
trials,clinical |
R47 |
T51 |
T52 |
arg1Of |
trials,exist |
R48 |
T52 |
T53 |
arg1Of |
exist,on |
R49 |
T55 |
T53 |
arg2Of |
use,on |
R50 |
T55 |
T54 |
arg1Of |
use,the |
R51 |
T55 |
T56 |
arg1Of |
use,of |
R52 |
T57 |
T56 |
arg2Of |
corticosteroids,of |
R53 |
T55 |
T58 |
arg1Of |
use,for |
R54 |
T59 |
T58 |
arg2Of |
COVID-19,for |
R55 |
T62 |
T60 |
arg1Of |
correlates,• |
R56 |
T61 |
T62 |
arg1Of |
IL6,correlates |
R57 |
T62 |
T63 |
arg1Of |
correlates,with |
R58 |
T71 |
T63 |
arg2Of |
and,with |
R59 |
T64 |
T65 |
arg1Of |
severity,"," |
R60 |
T66 |
T65 |
arg2Of |
criticality,"," |
R61 |
T65 |
T67 |
arg1Of |
",","," |
R62 |
T69 |
T67 |
arg2Of |
load,"," |
R63 |
T69 |
T68 |
arg1Of |
load,viral |
R64 |
T71 |
T70 |
arg1Of |
and,"," |
R65 |
T67 |
T71 |
arg1Of |
",",and |
R66 |
T72 |
T71 |
arg2Of |
prognosis,and |
R67 |
T72 |
T73 |
arg1Of |
prognosis,of |
R68 |
T74 |
T73 |
arg2Of |
COVID-19,of |
R69 |
T82 |
T75 |
arg1Of |
confer,• |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R73 |
T82 |
T80 |
arg1Of |
confer,"," |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
R75 |
T82 |
T81 |
arg2Of |
confer,can |
R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
R78 |
T82 |
T84 |
arg1Of |
confer,in |
R79 |
T85 |
T84 |
arg2Of |
patients,in |
R80 |
T85 |
T86 |
arg1Of |
patients,with |
R81 |
T88 |
T86 |
arg2Of |
and,with |
R82 |
T87 |
T88 |
arg1Of |
COVID-19,and |
R83 |
T90 |
T88 |
arg2Of |
IL6,and |
R84 |
T90 |
T89 |
arg1Of |
IL6,high |
R85 |
T94 |
T92 |
arg1Of |
coronavirus,The |
R86 |
T94 |
T93 |
arg1Of |
coronavirus,novel |
R87 |
T94 |
T95 |
arg1Of |
coronavirus,"," |
R88 |
T96 |
T95 |
arg2Of |
SARS-CoV2,"," |
R89 |
T99 |
T97 |
arg1Of |
cause,"," |
R90 |
T94 |
T98 |
arg1Of |
coronavirus,can |
R91 |
T99 |
T98 |
arg2Of |
cause,can |
R92 |
T94 |
T99 |
arg1Of |
coronavirus,cause |
R93 |
T103 |
T99 |
arg2Of |
disease,cause |
R94 |
T103 |
T100 |
arg1Of |
disease,a |
R95 |
T102 |
T101 |
arg1Of |
fatal,potentially |
R96 |
T103 |
T102 |
arg1Of |
disease,fatal |
R97 |
T103 |
T104 |
arg1Of |
disease,"," |
R98 |
T105 |
T104 |
arg2Of |
COVID-19,"," |
R99 |
T99 |
T106 |
arg1Of |
cause,"," |